GB201614235D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201614235D0
GB201614235D0 GBGB1614235.8A GB201614235A GB201614235D0 GB 201614235 D0 GB201614235 D0 GB 201614235D0 GB 201614235 A GB201614235 A GB 201614235A GB 201614235 D0 GB201614235 D0 GB 201614235D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1614235.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Achieve Pharma UK Ltd
Original Assignee
Achieve Pharma UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achieve Pharma UK Ltd filed Critical Achieve Pharma UK Ltd
Priority to GBGB1614235.8A priority Critical patent/GB201614235D0/en
Publication of GB201614235D0 publication Critical patent/GB201614235D0/en
Priority to PCT/GB2017/052438 priority patent/WO2018033742A2/en
Priority to DK17771833.5T priority patent/DK3500572T3/en
Priority to JP2019510286A priority patent/JP7178538B2/en
Priority to HUE17771833A priority patent/HUE061016T2/en
Priority to GB1713217.6A priority patent/GB2558700B/en
Priority to HRP20221497TT priority patent/HRP20221497T1/en
Priority to AU2017313390A priority patent/AU2017313390A1/en
Priority to US16/326,615 priority patent/US11667638B2/en
Priority to CA3032899A priority patent/CA3032899A1/en
Priority to EP22190758.7A priority patent/EP4112620A1/en
Priority to CN201780062052.3A priority patent/CN110088106A/en
Priority to ES17771833T priority patent/ES2935204T3/en
Priority to EP17771833.5A priority patent/EP3500572B1/en
Priority to RS20230001A priority patent/RS63872B1/en
Priority to LTEPPCT/GB2017/052438T priority patent/LT3500572T/en
Priority to PL17771833.5T priority patent/PL3500572T3/en
Priority to AU2021261840A priority patent/AU2021261840B2/en
Priority to JP2022124718A priority patent/JP2022159381A/en
Priority to US18/178,176 priority patent/US11905287B2/en
Priority to AU2023248084A priority patent/AU2023248084A1/en
Ceased legal-status Critical Current

Links

GBGB1614235.8A 2016-08-19 2016-08-19 Compounds Ceased GB201614235D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB1614235.8A GB201614235D0 (en) 2016-08-19 2016-08-19 Compounds
PL17771833.5T PL3500572T3 (en) 2016-08-19 2017-08-17 Cytisine derivatives for the treatment of addiction
EP22190758.7A EP4112620A1 (en) 2016-08-19 2017-08-17 Cytisine derivatives for the treatment of addiction
ES17771833T ES2935204T3 (en) 2016-08-19 2017-08-17 Cytisine derivatives for addiction treatment
JP2019510286A JP7178538B2 (en) 2016-08-19 2017-08-17 Compound
HUE17771833A HUE061016T2 (en) 2016-08-19 2017-08-17 Cytisine derivatives for the treatment of addiction
GB1713217.6A GB2558700B (en) 2016-08-19 2017-08-17 4-substituted Analogs of Cytisine
HRP20221497TT HRP20221497T1 (en) 2016-08-19 2017-08-17 Cytisine derivatives for the treatment of addiction
AU2017313390A AU2017313390A1 (en) 2016-08-19 2017-08-17 Cytisine derivatives for the treatment of addiction
US16/326,615 US11667638B2 (en) 2016-08-19 2017-08-17 4-substitued cytisine analogues
CA3032899A CA3032899A1 (en) 2016-08-19 2017-08-17 Compounds
PCT/GB2017/052438 WO2018033742A2 (en) 2016-08-19 2017-08-17 Compounds
CN201780062052.3A CN110088106A (en) 2016-08-19 2017-08-17 Compound
DK17771833.5T DK3500572T3 (en) 2016-08-19 2017-08-17 CYTISIS DERIVATIVES FOR THE TREATMENT OF ADDICTION
EP17771833.5A EP3500572B1 (en) 2016-08-19 2017-08-17 Cytisine derivatives for the treatment of addiction
RS20230001A RS63872B1 (en) 2016-08-19 2017-08-17 Cytisine derivatives for the treatment of addiction
LTEPPCT/GB2017/052438T LT3500572T (en) 2016-08-19 2017-08-17 Cytisine derivatives for the treatment of addiction
AU2021261840A AU2021261840B2 (en) 2016-08-19 2021-11-01 Compounds
JP2022124718A JP2022159381A (en) 2016-08-19 2022-08-04 Compounds
US18/178,176 US11905287B2 (en) 2016-08-19 2023-03-03 4-substitued cytisine analogues
AU2023248084A AU2023248084A1 (en) 2016-08-19 2023-10-10 Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1614235.8A GB201614235D0 (en) 2016-08-19 2016-08-19 Compounds

Publications (1)

Publication Number Publication Date
GB201614235D0 true GB201614235D0 (en) 2016-10-05

Family

ID=57045473

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1614235.8A Ceased GB201614235D0 (en) 2016-08-19 2016-08-19 Compounds

Country Status (1)

Country Link
GB (1) GB201614235D0 (en)

Similar Documents

Publication Publication Date Title
IL286839A (en) Propyne-indole compounds
GB201604647D0 (en) Novel compounds
GB201604638D0 (en) Novel compounds
GB201602854D0 (en) Novel compounds
GB201603779D0 (en) Novel compounds
GB201602934D0 (en) Compounds
GB201604020D0 (en) Compounds
GB201604027D0 (en) Compounds
GB201610854D0 (en) Compounds
GB201619694D0 (en) Compounds
GB201620119D0 (en) Compounds
GB201608777D0 (en) Compounds
IL263228A (en) Benzoxaborole compounds
GB201604022D0 (en) Compounds
SI3464336T1 (en) Compounds
GB201604030D0 (en) Compounds
GB201613946D0 (en) Compounds
GB201713217D0 (en) Compounds
GB201621520D0 (en) Compounds
GB201604029D0 (en) Compounds
GB201601301D0 (en) Novel compounds
GB201622362D0 (en) Compounds
GB201622365D0 (en) Compounds
GB201604031D0 (en) Compounds
GB201600899D0 (en) Intermediate compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)